Dr. Shenglan Tang is Co-Director of Global Health Program and Professor at Duke Kunshan University. He is Mary D.B.T. and James Semans Professor at Department of Population Health Science in the Duke University School of Medicine and Professor of Global Health at SingHealth-Duke-NUS Global Health Institute.

Dr. Tang has more than 30 years of experience undertaking research on health systems reform, disease control and maternal and child health in China and other countries, and has provided consultancy services on health systems strengthening to many international organizations and governments of developing countries. In 2012, Tang came to Duke from the UNICEF/UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases (TDR), based in Geneva, where he was Unit Leader for TB/HIV and Health Systems. Before his assignment at WHO, Tang was a faculty member at Liverpool School of Tropical Medicine in UK, and School of Public Health of Fudan University (former Shanghai Medical University).

Dr. Fujie Xu is an infectious disease physician and an epidemiologist with nearly 30 years of experience in public health research and project management in the United States, China and around the world. She joined DKU as the Co-Director of the Global Health Program in January 2025. In this role, Dr. Xu is dedicated to minimize all existing or emerging infectious disease threats and promote the vision of “health for all” by cultivating a new generation of global health talents.

Dr. Xu will focus on health innovations and their implementation. Her research and project interests will cover:

• Develop health innovations to address infectious diseases and possible pandemics, including applying genomic sequencing technology to understand the transmission dynamics and to detect emerging infections or variants and guide the development of countermeasures of vaccines and diagnostics; collaborating with Duke-NUS to introduce the technology into Asian countries (check the initiative); and accelerating the innovation and adoption of NGS for global health.
• Promote evidence generation, guideline development, and partnership to create real-world impact, including enhancing the partnership with public and private sectors that may involve government agencies, pharmaceutical or biotechnology companies, academia, and philanthropic funders in China and beyond for advocacy and global health practices.

Dr. Xu graduated from Peking Medical University (currently the Peking University Health Science Center) and received her PhD in Epidemiology from the Rollins School of Public Health, Emory University. Her past career experiences include the United States Centers for Disease Control and Prevention, Gilead Sciences, and Zhejiang University. In May 2020, she joined the Bill & Melinda Gates Foundation China Country Office as Deputy Director for Health Innovation and Partnerships to accelerate the development of vaccines, diagnostics and antimicrobials against pandemic and endemic infectious diseases.

Qian Long is an Associate Professor of Global Health at Duke Kunshan University. Dr. Long had medical and international health training in China and the Netherland. She completed her doctoral degree at the University of Helsinki, Finland, and had postdoctoral training at Duke Global Health Institute, Duke University and Duke Kunshan University. Her research interest and experience centers on health equity in relation to health systems development (with a focus on health financing and health services organization and delivery), including maternal and child health, tuberculosis control, and non-communicable diseases management in poor areas and among vulnerable groups of China and other low- and middle-income countries. Prior to joining Duke Kunshan University, she worked in the Department of Reproductive Health and Research, World Health Organization, based in Geneva for over two years.